Discontinuation report HEPSERA
Report ID | 171243 |
Drug Identification Number | 02247823 |
Brand name | HEPSERA |
Common or Proper name | adefovir dipivoxil |
Company Name | GILEAD SCIENCES CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ADEFOVIR DIPIVOXIL |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 tablets per bottle |
ATC code | J05AF |
ATC description | DIRECT ACTING ANTIVIRALS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2022-12-21 |
Actual discontinuation date | 2022-12-21 |
Remaining supply date | 2023-03-15 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | Global Discontinuation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6925 CENTURY AVENUE, SUITE 400 MISSISSAUGA, ONTARIO CANADA L5N 7K2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-12-27 | French | Compare |
v5 | 2022-12-27 | English | Compare |
v4 | 2022-11-14 | French | Compare |
v3 | 2022-11-14 | English | Compare |
v2 | 2022-10-06 | French | Compare |
v1 | 2022-10-06 | English | Compare |
Showing 1 to 6 of 6